These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 4633061

  • 1. Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis.
    Br Med J; 1973 Apr 07; 2(5857):7-11. PubMed ID: 4633061
    [Abstract] [Full Text] [Related]

  • 2. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar 07; 54(1):23-45. PubMed ID: 4204397
    [No Abstract] [Full Text] [Related]

  • 3. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 1. First report: the results at 12 months.
    WHO Collaborating Centre for Tuberculosis Chemotherapy.
    Bull World Health Organ; 1971 Mar 07; 45(5):573-93. PubMed ID: 4947492
    [Abstract] [Full Text] [Related]

  • 4. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
    Tubercle; 1973 Jun 07; 54(2):99-129. PubMed ID: 4203162
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H, Azuma Y.
    Kekkaku; 1975 Jul 07; 50(7):191-7. PubMed ID: 810615
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec 06; 2(7945):1105-9. PubMed ID: 53598
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
    Tubercle; 1975 Jun 06; 56(2):81-96. PubMed ID: 1103400
    [Abstract] [Full Text] [Related]

  • 15. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug 06; 46(8):325-33. PubMed ID: 4998863
    [No Abstract] [Full Text] [Related]

  • 16. A two-year follow-up of patients with quiescent pulmonary tuberculosis following a year of chemotherapy with an intermittent (twice-weekly) regimen of isoniazid plus streptomycin or a daily regimen of isoniazid plus PAS.
    Nazareth O, Devadatta S, Evans C, Fox W, Janardhanam B, Menon NK, Radhakrishna S, Ramakrishnan CV, Stott H, Tripathy SP, Velu S.
    Tubercle; 1966 Jun 06; 47(2):178-89. PubMed ID: 5963586
    [No Abstract] [Full Text] [Related]

  • 17. A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis.
    Tuberculosis Chemotherapy Centre.
    Bull World Health Organ; 1970 Jun 06; 43(1):143-206. PubMed ID: 5312317
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.